Last $54.72 USD
Change Today -0.97 / -1.74%
Volume 1.5M
RARE On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Geoffrey M. Duyk M.D., Ph.D.

AgeTotal Calculated CompensationThis person is connected to 112 board members in 13 different organizations across 20 different industries.

See Board Relationships
55--

Background*

Dr. Geoffrey M. Duyk, also known as Geoff, M.D., Ph.D., serves as a Partner at TPG Biotech and serves as its Managing Director. Dr. Duyk serves as the Managing Director at TPG Growth. Dr. Duyk served as President of Research & Development at Exelixis Inc. from January 2003 to December 2003. Dr. Duyk served as Exelixis Inc.'s Executive Vice President and Chief Scientific Officer from April 1997 to December 2002. Previously, Dr. Duyk was one of the founding scientific ...

Read Full Background

Corporate Headquarters*

60 Leveroni Court
Novato, California 94949

United States

Phone: 415-483-8800
Fax: 415-483-8810

Board Members Memberships*

Former President of Research & Development and Director
Former Director
Director
Former Director
Director
Director
Director
Director
Director
Former Director
Director
Director
Member of the Board of Directors
Director
2004-N/A
Former Director, Chairman of Corporate Governance & Nominating Committee and Member of Compensation Committee
2005-Present
Director and Member of Audit Committee
2007-2009
Former Director
2007-Present
Chairperson
2012-Present
Director and Member of Audit Committee

Education*

PhD
Case Western Reserve University
MD
Case Western Reserve University
Post-Doctoral Training
University of California-San Francisco
BA 1980
Wesleyan University
Post-Doctoral Training
Howard Hughes Medical Institute in Dallas

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RARE:US $54.72 USD -0.97

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ULTRAGENYX PHARMACEUTICAL IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.